<DOC>
	<DOCNO>NCT00737867</DOCNO>
	<brief_summary>The purpose study explore combination vinorelbine gemcitabine well vinorelbine carboplatin treatment advance non-small cell lung cancer , term survival , quality life need palliative radiotherapy .</brief_summary>
	<brief_title>Vinorelbine/Gemcitabine Versus Vinorelbine/Carboplatin Advanced Non-small Cell Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Vinorelbine</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Vinblastine</mesh_term>
	<criteria>Nonsmall cell lung cancer stage IIIB IV Not eligible radical radiotherapy surgery WHO performance status 02 Pregnancy Other clinical active cancer disease ALAT/ALP 3 time upper normal limit , bilirubin &gt; 1.5 upper limit Bowel disease cause malabsorption</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>lung cancer</keyword>
	<keyword>chemotherapy</keyword>
	<keyword>vinorelbine</keyword>
	<keyword>gemcitabine</keyword>
	<keyword>carboplatin</keyword>
	<keyword>advanced lung cancer</keyword>
	<keyword>non-small cell lung cancer</keyword>
</DOC>